# A conceptual framework for the public health monitoring of substance-related harms

**Authors:** Heather M. Orpana, Aganeta Enns, Megan Striha, Diana George, Abban Yusuf, Stephanie L. Hughes, Le Li, Laura H. Thompson

PMC · DOI: 10.24095/hpcdp.45.2.02 · Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice · 2025-02-01

## TL;DR

This paper introduces a new framework to guide public health monitoring of substance-related harms, aiming to improve data collection and policy responses.

## Contribution

The novel contribution is the development of a comprehensive conceptual framework for monitoring substance-related harms in public health.

## Key findings

- The framework includes four primary topic areas and four cross-cutting areas for a holistic approach.
- It identifies gaps in current monitoring systems and provides guidance for future data collection.
- The framework emphasizes respectful data use and stakeholder engagement.

## Abstract

The drug toxicity crisis in Canada and elsewhere has increased the need for timely and relevant data to inform policies and programs aimed at mitigating substance-related harms. While a number of monitoring systems addressing specific components of substance use and related harms in Canada exist, they are not guided by an overarching conceptual framework. This evidence-informed policy brief describes the development of a conceptual framework for the public health monitoring of substance-related harms. The resulting framework includes four primary topic areas (risk and protective factors, substance use, health supporting systems and substance-related harms and benefits); four cross-cutting topic areas (life course, equity, substance use stigma and mental and physical health and illness); and two overarching considerations (respectful use of data and engagement). This framework can be used to organize existing activities and to identify data and monitoring gaps for further development.

## Full-text entities

- **Diseases:** mental and physical health and illness (OMIM:603663), substance use (MESH:D019966), drug toxicity (MESH:D064420)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11987590/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11987590/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC11987590/full.md

---
Source: https://tomesphere.com/paper/PMC11987590